Literature DB >> 11191103

Allergic rhinitis update: Epidemiology and natural history.

J A Bellanti1, D B Wallerstedt.   

Abstract

Allergic rhinitis is the most common chronic condition, with an estimated prevalence in the United States of 5-22%, which increases from infancy, peaks in childhood and adolescence, and decreases in the elderly. As a major cause of morbidity, absenteeism, and restricted activity in both children and adults, allergic rhinitis, similar to asthma, appears to be increasing with time. Allergic rhinitis is commonly defined as seasonal or perennial, depending upon whether symptoms are manifested at defined yearly intervals or throughout the year, respectively. While trees, grasses, weeds, and molds are the most frequent causes of seasonal allergic rhinitis, dust mites and molds are the major contributors to perennial allergic rhinitis. The pathogenesis of allergic rhinitis is based upon interactions of allergen with membrane-bound allergen-specific IgE on the surface of mediator cells, i.e., basophils and mast cells, leading to the release of allergic mediators (both performed and newly synthesized) including histamine, leukotrienes, and eosinophil cationic protein (ECP). These are responsible for both immediate allergic responses characteristic of acute allergic rhinitis and the late inflammatory reactions responsible for chronic allergic rhinitis. The evaluation of rhinitis should include a detailed patient history, a careful physical examination, and appropriate diagnostic tests including skin prick tests or serum assays for allergen-specific IgE. Seasonal allergic rhinitis is readily distinguished from perennial allergic rhinitis by history and confirmed by positive skin tests to causative aeroallergens. It is important to differentiate seasonal rhinitis from non-allergic disorders including infectious rhinitis, structural or anatomic problems such as nasal polyps or septal deviation, rhinitis medicamentosa (due to the overuse of topical vasoconstrictors), hormonal rhinopathy (e.g., pregnancy, hypothyroidism), non-allergic vasomotor rhinopathy, non-allergic inflammatory rhinitis with eosinophils (NARES), or rarely, a neoplasm. A knowledge of the epidemiologic and clinical presentation of allergic rhinitis together with these pathophysiologic mechanisms is essential for a modern-day diagnostic and therapeutic approach to the patient who suffers from allergic rhinitis.

Entities:  

Mesh:

Year:  2000        PMID: 11191103     DOI: 10.2500/108854100778249088

Source DB:  PubMed          Journal:  Allergy Asthma Proc        ISSN: 1088-5412            Impact factor:   2.587


  20 in total

Review 1.  The economic burden of allergic rhinitis: a critical evaluation of the literature.

Authors:  Shelby D Reed; Todd A Lee; Douglas C McCrory
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

2.  The effect of allergic rhinitis with positive skin prick test on choroidal thickness.

Authors:  Alper Yenigun; Ahmet Elbay; Remzi Dogan; Orhan Ozturan; Mehmet Hakan Ozdemir
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-03-06       Impact factor: 2.503

3.  Development and validity of the DyNaChron questionnaire for chronic nasal dysfunction.

Authors:  Sophie Kacha; Francis Guillemin; Roger Jankowski
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-07-08       Impact factor: 2.503

4.  Increased risk of dental trauma in patients with allergic rhinitis: A nationwide population-based cohort study.

Authors:  Ming-Jhih Siao; Gunng-Shinng Chen; Wei-Cheng Lee; Jorng-Tzong Horng; Cheng-Wei Chang; Chung-Hsing Li
Journal:  PLoS One       Date:  2017-07-31       Impact factor: 3.240

Review 5.  The Role of Allergic Rhinitis in Chronic Rhinosinusitis.

Authors:  Samuel N Helman; Emily Barrow; Thomas Edwards; John M DelGaudio; Joshua M Levy; Sarah K Wise
Journal:  Immunol Allergy Clin North Am       Date:  2020-01-14       Impact factor: 3.479

6.  Audiological findings in pediatric perineal allergic rhinitis (house dust mite allergy) patients.

Authors:  Mustafa Atilla Nursoy; Fadlullah Aksoy; Remzi Dogan; Orhan Ozturan; Sabri Baki Eren; Bayram Veyseller; Emin Ozkaya; Ayşegul Dogan Demir; Burak Ozturk
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-07-26       Impact factor: 2.503

7.  Epidemiological features of allergic rhinitis in four major cities in Western China.

Authors:  Ji Shen; Xia Ke; Suling Hong; Qing Zeng; Chuanyu Liang; Tongying Li; Anzhou Tang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2011-08-07

8.  Clinical efficacy and safety of a combined loratadine-betamethasone oral solution in the treatment of severe pediatric perennial allergic rhinitis.

Authors:  Teolinda Mendoza de Morales; Francis Sánchez
Journal:  World Allergy Organ J       Date:  2009-04       Impact factor: 4.084

9.  Safety and tolerability of fluticasone furoate nasal spray once daily in paediatric patients aged 6-11 years with allergic rhinitis: subanalysis of three randomized, double-blind, placebo-controlled, multicentre studies.

Authors:  Eli O Meltzer; Ita Tripathy; Jorge F Máspero; Wei Wu; Ed Philpot
Journal:  Clin Drug Investig       Date:  2009       Impact factor: 2.859

10.  Symptoms treatment for allergic rhinitis using diode laser: results after 6-year follow-up.

Authors:  Yao-Lung Tsai; Chin-Chuan Su; Hong-Shen Lee; Hui-Chuan Chen; Mu-Kuan Chen
Journal:  Lasers Med Sci       Date:  2008-04-17       Impact factor: 3.161

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.